{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T15:47:08Z","timestamp":1784130428694,"version":"3.55.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol Exp"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Gd levels are higher in tissues of animals with compromised renal function, but studies to compare levels after exposure to different macrocyclic gadolinium-based contrast agents (GBCAs) are lacking. We compared Gd levels in tissues of subtotally nephrectomised (SN) rats after repeated exposure to macrocyclic GBCAs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Sprague\u2013Dawley SN male rats (19 per group) received 16 injections of gadoteridol, gadobutrol, or gadoterate meglumine at 0.6\u00a0mmol Gd\/kg 4 times\/weeks over 4\u00a0weeks. A control group of healthy male rats (<jats:italic>n<\/jats:italic>\u2009=\u200910) received gadoteridol at the same dosage. Plasma urea and creatinine levels were monitored. Blood, cerebrum, cerebellum, liver, femur, kidney(s), skin and peripheral nerves were harvested for Gd determination by inductively coupled plasma-mass spectrometry at 28 and 56\u00a0days after the end of treatment.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Plasma urea and creatinine levels were roughly twofold higher in SN rats than in healthy rats at all timepoints. At day 28, Gd levels in the peripheral nerves of gadobutrol- or gadoterate-treated SN animals were 5.4 or 7.2 times higher than in gadoteridol-treated animals (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). Higher Gd levels after administration of gadobutrol or gadoterate <jats:italic>versus<\/jats:italic> gadoteridol were also determined in kidneys (<jats:italic>p<\/jats:italic>\u2009\u2264\u20090.002),  cerebrum (<jats:italic>p<\/jats:italic>\u2009\u2264\u20090.001), cerebellum (<jats:italic>p<\/jats:italic>\u2009\u2264\u20090.003), skin (<jats:italic>p<\/jats:italic>\u2009\u2265\u20090.244), liver (<jats:italic>p<\/jats:italic>\u2009\u2265\u20090.053), and femur (<jats:italic>p<\/jats:italic>\u2009\u2265\u20090.271). At day 56, lower Gd levels were determined both in SN and healthy rats for all GBCAs and tissues, except the femur.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Gd tissue levels were lower following gadoteridol exposure than following gadobutrol or gadoterate exposure.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s41747-023-00324-1","type":"journal-article","created":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T01:02:46Z","timestamp":1677632566000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Gadolinium retention in a rat model of subtotal renal failure: are there differences among macrocyclic GBCAs?"],"prefix":"10.1186","volume":"7","author":[{"given":"Roberta","family":"Bonaf\u00e8","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Coppo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Queliti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6619-0404","authenticated-orcid":false,"given":"Simona","family":"Bussi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Maisano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miles A.","family":"Kirchin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Tedoldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,1]]},"reference":[{"key":"324_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12325-015-0275-4","volume":"33","author":"J Lohrke","year":"2016","unstructured":"Lohrke J, Frenzel T, Endrikat J et al (2016) 25 years of contrast-enhanced MRI: developments, current challenges and future perspectives. Adv Ther 33:1\u201328. https:\/\/doi.org\/10.1007\/s12325-015-0275-4","journal-title":"Adv Ther"},{"key":"324_CR2","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1002\/jmri.21969","volume":"30","author":"S Aime","year":"2009","unstructured":"Aime S, Caravan P (2009) Biodistribution of gadolinium-based contrast agents, including gadolinium deposition. J Magn Reason Imaging 30:1259\u20131267. https:\/\/doi.org\/10.1002\/jmri.21969","journal-title":"J Magn Reason Imaging"},{"key":"324_CR3","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1093\/ndt\/gfk062","volume":"21","author":"T Grobner","year":"2005","unstructured":"Grobner T (2005) Gadolinium\u2013a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transplant 21:1104\u20131108. https:\/\/doi.org\/10.1093\/ndt\/gfk062","journal-title":"Nephrol Dial Transplant"},{"key":"324_CR4","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1148\/radiol.13131669","volume":"270","author":"T Kanda","year":"2014","unstructured":"Kanda T, Ishii K, Kawaguchi H, Kitajima K, Takenaka D (2014) High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images: relationship with increasing cumulative dose of a gadolinium-based contrast material. Radiology 270:834\u2013841. https:\/\/doi.org\/10.1148\/radiol.13131669","journal-title":"Radiology"},{"key":"324_CR5","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1097\/RLI.0000000000000252","volume":"51","author":"N Murata","year":"2016","unstructured":"Murata N, Gonzalez-Cuyar LF, Murata K et al (2016) Macrocyclic and other non-group 1 gadolinium contrast agents deposit low levels of gadolinium in brain and bone tissue: Preliminary results from 9 patients with normal renal function. Invest Radiol 51:447\u2013453. https:\/\/doi.org\/10.1097\/RLI.0000000000000252","journal-title":"Invest Radiol"},{"key":"324_CR6","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/RLI.0000000000000181","volume":"50","author":"P Robert","year":"2015","unstructured":"Robert P, Lehericy S, Grand S et al (2015) T1-weighted hypersignal in the deep cerebellar nuclei after repeated administrations of Gd-based contrast agents in healthy rats: difference between linear and macrocyclic Agents. Invest Radiol 50:473\u2013480. https:\/\/doi.org\/10.1097\/RLI.0000000000000181","journal-title":"Invest Radiol"},{"key":"324_CR7","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1097\/RLI.0000000000000241","volume":"51","author":"P Robert","year":"2016","unstructured":"Robert P, Violas X, Grand S et al (2016) Linear gadolinium-based contrast agents are associated with brain gadolinium retention in healthy rats. Invest Radiol 51:73\u201382. https:\/\/doi.org\/10.1097\/RLI.0000000000000241","journal-title":"Invest Radiol"},{"key":"324_CR8","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1097\/RLI.0000000000000242","volume":"51","author":"G Jost","year":"2016","unstructured":"Jost G, Lenhard DC, Sieber MA, Lohrke J, Frenzel T, Pietsch H (2016) Signal increase on unenhanced T1-weighted images in the rat brain after repeated, extended doses of gadolinium-based contrast agents: comparison of linear and macrocyclic agents. Invest Radiol 51:83\u201389. https:\/\/doi.org\/10.1097\/RLI.0000000000000242","journal-title":"Invest Radiol"},{"key":"324_CR9","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1097\/RLI.0000000000000352","volume":"52","author":"T Frenzel","year":"2017","unstructured":"Frenzel T, Apte C, Jost G, Sch\u00f6ckel L, Lohrke J, Pietsch H (2017) Quantification and assessment of the chemical form of residual gadolinium in the brain after repeated administration of gadolinium-based contrast agents: comparative study in rats. Invest Radiol 52:396\u2013404. https:\/\/doi.org\/10.1097\/RLI.0000000000000352","journal-title":"Invest Radiol"},{"key":"324_CR10","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1148\/radiol.2016160905","volume":"282","author":"AP Smith","year":"2017","unstructured":"Smith AP, Marino M, Roberts J et al (2017) Clearance of gadolinium from the brain with no pathologic effect after repeated administration of gadodiamide in healthy rats: an analytical and histologic study. Radiology 282:743\u2013751. https:\/\/doi.org\/10.1148\/radiol.2016160905","journal-title":"Radiology"},{"key":"324_CR11","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1097\/RLI.0000000000000344","volume":"52","author":"J Lohrke","year":"2017","unstructured":"Lohrke J, Frisk AL, Frenzel T et al (2017) Histology and gadolinium distribution in the rodent brain after the administration of cumulative high doses of linear and macrocyclic gadolinium-based contrast agents. Invest Radiol 52:324\u2013333. https:\/\/doi.org\/10.1097\/RLI.0000000000000344","journal-title":"Invest Radiol"},{"issue":"2","key":"324_CR12","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1148\/radiol.2017161594","volume":"285","author":"RJ McDonald","year":"2017","unstructured":"McDonald RJ, McDonald JS, Dai D et al (2017) Comparison of gadolinium concentrations within multiple rat organs after intravenous administration of linear versus macrocyclic gadolinium chelates. Radiology 285(2):536\u2013545. https:\/\/doi.org\/10.1148\/radiol.2017161594","journal-title":"Radiology"},{"key":"324_CR13","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.1007\/s00330-016-4654-2","volume":"27","author":"G Jost","year":"2017","unstructured":"Jost G, Frenzel T, Lohrke J, Lenhard DC, Naganawa S, Pietsch H (2017) Penetration and distribution of gadolinium-based contrast agents into the cerebrospinal fluid in healthy rats: a potential pathway of entry into the brain tissue. Eur Radiol 27:2877\u20132885. https:\/\/doi.org\/10.1007\/s00330-016-4654-2","journal-title":"Eur Radiol"},{"key":"324_CR14","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.toxlet.2021.07.016","volume":"350","author":"Y Kong","year":"2021","unstructured":"Kong Y, Zhang S, Wang J et al (2021) Potential toxicity evaluation and comparison within multiple mice organs after repeat injections of linear versus macrocyclic gadolinium-based contrast agents: a comprehensive and time course study. Toxicol Lett 350:152\u2013161. https:\/\/doi.org\/10.1016\/j.toxlet.2021.07.016","journal-title":"Toxicol Lett"},{"key":"324_CR15","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1002\/jmri.25822","volume":"47","author":"S Bussi","year":"2018","unstructured":"Bussi S, Coppo A, Botteron C et al (2018) Differences in gadolinium retention after repeated injections of macrocyclic MR contrast agents to rats. J Magn Reson Imaging 47:746\u2013752. https:\/\/doi.org\/10.1002\/jmri.25822","journal-title":"J Magn Reson Imaging"},{"key":"324_CR16","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13244-019-0824-5","volume":"11","author":"S Bussi","year":"2020","unstructured":"Bussi S, Coppo A, Celeste R et al (2020) Macrocyclic MR contrast agents: evaluation of multiple-organ gadolinium retention in healthy rats. Insights Imaging 11:11. https:\/\/doi.org\/10.1186\/s13244-019-0824-5","journal-title":"Insights Imaging"},{"key":"324_CR17","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1148\/radiol.2018180135","volume":"290","author":"G Jost","year":"2019","unstructured":"Jost G, Frenzel T, Boyken J, Lohrke J, Nischwitz V, Pietsch H (2019) Long-term excretion of gadolinium-based contrast agents: linear versus macrocyclic agents in an experimental rat model. Radiology 290:340\u2013348. https:\/\/doi.org\/10.1148\/radiol.2018180135","journal-title":"Radiology"},{"key":"324_CR18","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1002\/jmri.27693","volume":"54","author":"S Bussi","year":"2021","unstructured":"Bussi S, Coppo A, Bonaf\u00e8 R et al (2021) Gadolinium clearance in the first 5 weeks after repeated intravenous administration of gadoteridol, gadoterate meglumine, and gadobutrol to rats. J Magn Reson Imaging 54:1636\u20131644. https:\/\/doi.org\/10.1002\/jmri.27693","journal-title":"J Magn Reson Imaging"},{"key":"324_CR19","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1097\/RLI.0000000000000295","volume":"51","author":"AA Kartamihardja","year":"2016","unstructured":"Kartamihardja AA, Nakajima T, Kameo S, Koyama H, Tsushima Y (2016) Impact of impaired renal function on gadolinium retention after administration of gadolinium-based contrast agents in a mouse model. Invest Radiol 51:655\u2013660. https:\/\/doi.org\/10.1097\/RLI.0000000000000295","journal-title":"Invest Radiol"},{"key":"324_CR20","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1097\/RLI.0000000000000339","volume":"52","author":"M Rasschaert","year":"2017","unstructured":"Rasschaert M, Id\u00e9e JM, Robert P et al (2017) Moderate renal failure accentuates T1 signal enhancement in the deep cerebellar nuclei of gadodiamide-treated rats. Invest Radiol 52:255\u2013264. https:\/\/doi.org\/10.1097\/RLI.0000000000000339","journal-title":"Invest Radiol"},{"key":"324_CR21","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1097\/RLI.0000000000000447","volume":"53","author":"M Rasschaert","year":"2018","unstructured":"Rasschaert M, Emerit A, Fretellier N et al (2018) Gadolinium retention, brain T1 hyperintensity, and endogenous metals: a comparative study of macrocyclic versus linear gadolinium chelates in renally sensitized rats. Invest Radiol 53:328\u2013337. https:\/\/doi.org\/10.1097\/RLI.0000000000000447","journal-title":"Invest Radiol"},{"key":"324_CR22","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1097\/RLI.0000000000000517","volume":"54","author":"N Fretellier","year":"2019","unstructured":"Fretellier N, Granottier A, Rasschaert M et al (2019) Does age interfere with gadolinium toxicity and presence in brain and bone tissues? A comparative gadoterate versus gadodiamide study in juvenile and adult rats. Invest Radiol 54:61\u201371. https:\/\/doi.org\/10.1097\/RLI.0000000000000517","journal-title":"Invest Radiol"},{"key":"324_CR23","unstructured":"U.S. Department of Health and Human Services, Food and Drug Administration Center for Drug Evaluation and Research (CDER) (2005) Guidance for Industry: Estimating the maximum safe starting dose in initial clinical trials for therapeutics in adult healthy volunteers. https:\/\/www.fda.gov\/downloads\/drugs\/guidances\/ucm078932.pdfAccessed 26 Aug 2022"},{"key":"324_CR24","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1080\/02664763.2010.545119","volume":"38","author":"G Barbato","year":"2001","unstructured":"Barbato G, Barini EM, Genta G, Levi R (2001) Features and performance of some outlier detection methods. J Appl Stat 38:2133\u20132149. https:\/\/doi.org\/10.1080\/02664763.2010.545119","journal-title":"J Appl Stat"},{"key":"324_CR25","doi-asserted-by":"publisher","first-page":"591","DOI":"10.2307\/2333709","volume":"52","author":"SS Shapiro","year":"1965","unstructured":"Shapiro SS, Bradbury Wilk M (1965) An analysis of variance test for normality (complete samples). Biometrika 52:591\u2013611. https:\/\/doi.org\/10.2307\/2333709","journal-title":"Biometrika"},{"key":"324_CR26","first-page":"278","volume-title":"Contributions to probability and statistics: Essays in Honor of Harold Hotelling","author":"H Levene","year":"1960","unstructured":"Levene H (1960) Robust tests for equality of variances. In: Olkin I, Hotelling H et al (eds) Contributions to probability and statistics: Essays in Honor of Harold Hotelling. Stanford University Press, Stanford, pp 278\u2013292"},{"key":"324_CR27","unstructured":"Statistical Methods (sixth edition) (1967). Snedecor and Cochrane. The Iowa State University Press. ISBN9780813815602"},{"key":"324_CR28","doi-asserted-by":"publisher","unstructured":"Biostatistics (Second Edition) (2004). Gerald Van Belle, Lloyd D. Fisher, Patrick J. Heagerty, Thomas Lumley. John Wiley & Sons, Inc.\u00a0https:\/\/doi.org\/10.1002\/0471602396","DOI":"10.1002\/0471602396"},{"key":"324_CR29","doi-asserted-by":"publisher","first-page":"134","DOI":"10.2307\/2683979","volume":"35","author":"MR Stoline","year":"1981","unstructured":"Stoline MR (1981) The status of multiple comparisons: simultaneous estimation of all pairwise comparisons in one-way ANOVA designs. Am Stat 35:134\u2013141. https:\/\/doi.org\/10.2307\/2683979","journal-title":"Am Stat"},{"key":"324_CR30","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1097\/RLI.0000000000000793","volume":"56","author":"N Fretellier","year":"2021","unstructured":"Fretellier N, Rasschaert M, Bocanegra J et al (2021) Safety and gadolinium distribution of the new high-relaxivity gadolinium chelate gadopiclenol in a rat model of severe renal failure. Invest Radiol 56:826\u2013836. https:\/\/doi.org\/10.1097\/RLI.0000000000000793","journal-title":"Invest Radiol"},{"key":"324_CR31","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1148\/radiol.2019182748","volume":"291","author":"S Aime","year":"2019","unstructured":"Aime S (2019) Differences in molecular structure markedly affect GBCA elimination behavior. Radiology 291:267\u2013268. https:\/\/doi.org\/10.1148\/radiol.2019182748","journal-title":"Radiology"},{"key":"324_CR32","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1148\/radiol.2020192645","volume":"297","author":"SM Alkhunizi","year":"2020","unstructured":"Alkhunizi SM, Fakhoury M, Abou-Kheir W, Lawand N (2020) Gadolinium retention in the central and peripheral nervous system: implication for pain, cognition, and neurogenesis. Radiology 297:407\u2013416. https:\/\/doi.org\/10.1148\/radiol.2020192645","journal-title":"Radiology"},{"key":"324_CR33","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/RLI.0000000000000677","volume":"55","author":"A Radbruch","year":"2020","unstructured":"Radbruch A, Richter H, B\u00fccker P et al (2020) Is small fiber neuropathy induced by gadolinium-based contrast agents? Invest Radiol 55:473\u2013480. https:\/\/doi.org\/10.1097\/RLI.0000000000000677","journal-title":"Invest Radiol"},{"key":"324_CR34","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1515\/revneuro-2013-0022","volume":"24","author":"X Gao","year":"2013","unstructured":"Gao X, Wang Y, Chen J et al (2013) The role of peripheral nerve ECM components in the tissue engineering nerve construction. Rev Neurosci 24:443\u2013453. https:\/\/doi.org\/10.1515\/revneuro-2013-0022","journal-title":"Rev Neurosci"},{"key":"324_CR35","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.biomaterials.2011.10.013","volume":"33","author":"SN Masand","year":"2012","unstructured":"Masand SN, Perron IJ, Schachner M, Shreiber DI (2012) Neural cell type-specific responses to glycomimetic functionalized collagen. Biomaterials 33:790\u2013797. https:\/\/doi.org\/10.1016\/j.biomaterials.2011.10.013","journal-title":"Biomaterials"},{"key":"324_CR36","doi-asserted-by":"publisher","first-page":"14863","DOI":"10.1039\/d0dt03314f","volume":"49","author":"N Guidolin","year":"2020","unstructured":"Guidolin N, Travagin F, Giovenzana GB et al (2020) Interaction of macrocyclic gadolinium-based MR contrast agents with type I collagen. Equilibrium and kinetic studies. Dalton Trans 49:14863\u201314870. https:\/\/doi.org\/10.1039\/d0dt03314f","journal-title":"Equilibrium and kinetic studies. Dalton Trans"},{"key":"324_CR37","volume-title":"Collagen; eBook ISBN9781351070799 CRC Press","author":"HM Liu","year":"1988","unstructured":"Liu HM (1988) Collagens in Nervous Tissue. Collagen; eBook ISBN9781351070799 CRC Press"},{"key":"324_CR38","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1148\/radiol.2016160905","volume":"282","author":"AP Smith","year":"2017","unstructured":"Smith AP, Marino M, Roberts J et al (2017) Clearance of gadolinium from the brain with no pathologic effect after repeated administration of gadodiamide in healthy rats: an analytical and histologic study. Radiology 282:743\u2013751. https:\/\/doi.org\/10.1148\/radiol.2016160905","journal-title":"Radiology"},{"key":"324_CR39","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1148\/radiol.2018172746","volume":"288","author":"P Robert","year":"2018","unstructured":"Robert P, Fingerhut S, Factor C et al (2018) One-year retention of gadolinium in the brain: comparison of gadodiamide and gadoterate meglumine in a rodent model. Radiology 288:424\u2013433. https:\/\/doi.org\/10.1148\/radiol.2018172746","journal-title":"Radiology"},{"key":"324_CR40","doi-asserted-by":"publisher","unstructured":"Andreollo NA, Santos EF, Ara\u00fajo MR, Lopes LR (2012) Rat\u2019s age versus human\u2019s age: what is the relationship? Arq Bras Cir Dig 25:49\u201351. https:\/\/doi.org\/10.1590\/S0102-67202012000100011","DOI":"10.1590\/S0102-67202012000100011"},{"key":"324_CR41","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1148\/radiol.212600","volume":"305","author":"SKI Funke","year":"2022","unstructured":"Funke SKI, Factor C, Rasschaert M et al (2022) Long-term gadolinium retention in the healthy rat brain: comparison between gadopiclenol, gadobutrol, and gadodiamide. Radiology 305:179\u2013189. https:\/\/doi.org\/10.1148\/radiol.212600","journal-title":"Radiology"}],"container-title":["European Radiology Experimental"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41747-023-00324-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41747-023-00324-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41747-023-00324-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T01:06:18Z","timestamp":1677632778000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurradiolexp.springeropen.com\/articles\/10.1186\/s41747-023-00324-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,1]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["324"],"URL":"https:\/\/doi.org\/10.1186\/s41747-023-00324-1","relation":{},"ISSN":["2509-9280"],"issn-type":[{"value":"2509-9280","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,1]]},"assertion":[{"value":"12 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal procedures were performed in accordance with Italian laws on animal protection. Ministry of Health authorisation n. 1229\/2020-PR, released on December 31, 2020, according to the article n. 31 of the D.lgs n. 26\/2014.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors were Bracco\u2019s employees at the time of study execution. They have not taken part in the review or selection process of this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7"}}